For the quarter ending 2026-03-31, CHMG had $3,273K increase in cash & cash equivalents over the period. $8,905K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 9,199 | 7,741 | 7,792 | -429 |
| Amortization of right-of-use assets | 211 | 771 | - | - |
| (increases in) amortization of right-of-use assets | - | - | 196 | 307 |
| Deferred income tax (benefit) expense | - | -2,673 | - | - |
| Provision for credit losses | 601 | 1,136 | 1,064 | 2,237 |
| Losses on disposal of fixed assets, net | 0 | 2 | 22 | 616 |
| Depreciation and amortization of fixed assets | 484 | 493 | 461 | 941 |
| Losses on securities transactions, net | - | - | 0 | -17,498 |
| Amortization of premiums on securities, net | -163 | -162 | -179 | -1,097 |
| Proceeds from sales of equity investments | - | - | 0 | 88 |
| (gains) on sales of loans held for sale, net | 21 | 92 | 78 | 91 |
| Proceeds from sales of loans held for sale | 1,156 | 4,810 | 4,439 | 4,842 |
| Increases in (payments on) operating lease liabilities | - | - | 195 | 310 |
| Loans originated and held for sale | 1,741 | 1,680 | 5,224 | 6,963 |
| Losses on sales of other real estate owned, net | 0 | 10 | 0 | -8 |
| Write-downs on other real estate owned | - | 0 | 0 | - |
| Change in fair value of equity investments, net | -71 | 14 | 136 | 61 |
| Losses on securities transactions, net | - | -17,498 | - | - |
| Purchases of equity investments, net | 82 | 47 | 93 | 179 |
| Amortization of deferred costs on subordinated debt | 26 | 26 | 26 | 4 |
| Losses (gains) on interest rate swaps, net | 5 | -42 | -2 | -66 |
| Income from bank owned life insurance | 7 | 8 | 8 | 16 |
| Decrease (increase) in accrued interest receivable | 102 | -361 | - | - |
| Decrease (increase) in other assets | -683 | -1,860 | -3,066 | 393 |
| Increase (decrease) in accrued interest payable | 589 | -126 | -1,435 | -69 |
| (decrease) in other liabilities | -2,334 | 3,969 | 1,861 | -1,687 |
| (payments on) operating leases | 199 | 772 | - | - |
| Expense related to restricted stock units for directors' deferred compensation plan | 6 | 6 | 6 | 11 |
| Expense related to employee restricted stock awards | 340 | 466 | 339 | 641 |
| Net cash provided by operating activities | 9,038 | 16,333 | 12,240 | 16,926 |
| Proceeds from sales of securities available for sale | - | - | 0 | 227,305 |
| Proceeds from sales, maturities and principal collected on securities held to maturity | - | 200 | 0 | 128 |
| Purchases of securities available for sale | - | 3,990 | - | - |
| Purchases of securities held to maturity | - | 160 | - | - |
| Proceeds from sales, maturities, calls, and principal paydowns on securities available for sale | 5,556 | 234,532 | 11,566 | 28,340 |
| Purchases of fhlbny and frbny stock | 7,040 | 4,800 | 1,267 | 10,322 |
| Redemption of fhlbny and frbny stock | 7,542 | 858 | 2,569 | 12,613 |
| Proceeds from sales of fixed assets | - | 82 | 23 | 1,300 |
| Purchases of premises and equipment | 133 | 599 | 400 | 688 |
| Proceeds from sale of other real estate owned | 0 | 66 | 0 | 347 |
| Proceeds from bank owned life insurance | 280 | - | - | - |
| (increase) in loans, net | 42,050 | 70,097 | 70,026 | 61,955 |
| Net cash (used in) investing activities | -35,845 | -71,213 | -57,535 | 197,068 |
| Increase in demand, interest-bearing demand, savings, and insured money market deposits | 48,897 | -66,623 | 23,189 | 77,521 |
| (decrease) in time deposits | -5,675 | -21,219 | -133,635 | -5,442 |
| Net increase (decrease) in fhlbny overnight advances | - | -22,000 | - | - |
| (decrease) in fhlbny overnight advances, net | 97,710 | - | -55,000 | -54,110 |
| (payments on) finance leases | 88 | 86 | 86 | 163 |
| Proceeds from subordinated debt issuance | - | 0 | 0 | 45,000 |
| Payment of subordinated debt issuance costs | - | 0 | 170 | 858 |
| Purchase of treasury stock | 173 | 295 | 11 | 90 |
| Sale of treasury stock | 158 | 74 | 233 | 229 |
| Cash dividends paid | 1,639 | 1,630 | 1,630 | 3,065 |
| Net cash provided by financing activities | 30,080 | -2,669 | -167,110 | 59,022 |
| Increase in cash and cash equivalents, net | 3,273 | -57,549 | -212,405 | 273,016 |
| Cash and cash equivalents, beginning of period | 50,097 | 107,646 | 47,035 | - |
| Cash and cash equivalents, end of period | 53,370 | 50,097 | 107,646 | - |
CHEMUNG FINANCIAL CORP (CHMG)
CHEMUNG FINANCIAL CORP (CHMG)